MPLT Smart Money
MapLight Therapeutics, Inc.
1W: -4.2%
1M: -26.8%
3M: -37.8%
YTD: -54.3%
$8.17
+0.51 (+6.66%)
After Hours: $7.83 (-0.33, -4.10%)
Weekly Expected Move ±7.7%
$7
$7
$8
$9
$9
Credit Risk of going bust: higher than 77% of companies Debt: 0.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.8%), MapLight Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.0M against a stock market value of $326.5M.
Distance to default 2.87 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 155.1%; Altman Z'' 15.02. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.02 (down 99.8%), MapLight Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.0M against a stock market value of $326.5M.
Distance to default 2.87 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 155.1%; Altman Z'' 15.02. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026119
Institutions Holding
+24 vs prior
243.6%
Ownership
+107.95%
39
New
22
Increased
39
Reduced
10
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Kroeger Christopher A. | officer: chief executive officer | S-Sale | 73,691 | $8.08 | $595K | Filing |
| 2026-10-15 | Foff Erin Pennock | officer: chief medical officer | S-Sale | 15,355 | $8.08 | $124K | Filing |
| 2026-10-15 | Hanson Kristopher | officer: general counsel | S-Sale | 9,020 | $8.08 | $73K | Filing |
| 2026-10-15 | Lillie James Woodruff | officer: chief scientific officer | S-Sale | 11,513 | $8.08 | $93K | Filing |
| 2026-10-15 | GILLIS JONATHAN | officer: cao and interim cfo | S-Sale | 10,167 | $8.08 | $82K | Filing |
| 2026-10-15 | Kreitzer Anatol | officer: chief discovery officer | S-Sale | 12,248 | $7.84 | $96K | Filing |
| 2026-09-16 | Hanson Kristopher | officer: general counsel | S-Sale | 16,509 | $11.67 | $193K | Filing |
| 2026-08-17 | GILLIS JONATHAN | officer: cao and interim cfo | A-Grant/Award | 6,020 | $— | $0 | Filing |
| 2026-08-17 | Kreitzer Anatol | officer: chief discovery officer | A-Grant/Award | 6,020 | $— | $0 | Filing |
| 2026-08-17 | GILLIS JONATHAN | officer: cao and interim cfo | A-Grant/Award | 2,222 | $— | $0 | Filing |
| 2026-08-17 | Lillie James Woodruff | officer: chief scientific officer | A-Grant/Award | 7,730 | $— | $0 | Filing |
| 2026-08-17 | Hanson Kristopher | officer: general counsel | A-Grant/Award | 7,730 | $— | $0 | Filing |
| 2026-08-17 | Foff Erin Pennock | officer: chief medical officer | A-Grant/Award | 13,360 | $— | $0 | Filing |
| 2026-08-17 | Kroeger Christopher A. | officer: chief executive officer | A-Grant/Award | 23,145 | $— | $0 | Filing |
| 2026-08-03 | Lillie James Woodruff | officer: chief scientific officer | S-Sale | 22,082 | $12.54 | $277K | Filing |
| 2026-07-28 | Cox Troy | director | P-Purchase | 15,620 | $9.52 | $149K | Filing |
| 2026-07-17 | Kreitzer Anatol | officer: chief discovery officer | S-Sale | 200 | $38.39 | $8K | Filing |
| 2026-07-17 | Hanson Kristopher | officer: general counsel | S-Sale | 1,130 | $37.90 | $43K | Filing |
| 2026-07-17 | Kreitzer Anatol | officer: chief discovery officer | S-Sale | 14,140 | $37.70 | $533K | Filing |
| 2026-07-17 | Kreitzer Anatol | officer: chief discovery officer | S-Sale | 2,833 | $37.05 | $105K | Filing |
| 2026-07-17 | GILLIS JONATHAN | officer: cao and interim cfo | S-Sale | 900 | $38.17 | $34K | Filing |
| 2026-07-17 | GILLIS JONATHAN | officer: cao and interim cfo | S-Sale | 16,969 | $37.61 | $638K | Filing |
| 2026-07-17 | GILLIS JONATHAN | officer: cao and interim cfo | S-Sale | 600 | $36.51 | $22K | Filing |
| 2026-07-17 | Lillie James Woodruff | officer: chief scientific officer | S-Sale | 2,077 | $37.90 | $79K | Filing |
| 2026-07-17 | Kroeger Christopher A. | officer: chief executive officer | S-Sale | 16,779 | $37.90 | $636K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 3,686,622 | $132M | — | 2026-06-30 | Filing |
| FCPM III SERVICES B.V. | 3,226,400 | $116M | — | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,948,312 | $70M | -46,561 | 2026-06-30 | Filing |
| BlackRock, Inc. | 1,025,134 | $37M | -314,597 | 2026-06-30 | Filing |
| Nan Fung Group Holdings Ltd | 971,253 | $35M | — | 2026-06-30 | Filing |
| 5AM Venture Management, LLC | 950,011 | $34M | — | 2026-06-30 | Filing |
| Sanofi | 912,041 | $33M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 852,150 | $31M | +513,034 | 2026-06-30 | Filing |
| FMR LLC | 823,556 | $30M | +619,055 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 784,150 | $28M | +64,330 | 2026-06-30 | Filing |
| Blue Owl Capital Holdings LP | 729,929 | $26M | -276,000 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 685,852 | $25M | +685,852 | 2026-06-30 | Filing |
| Pivotal bioVenture Partners Investment A | 611,446 | $22M | -1 | 2026-06-30 | Filing |
| Velan Capital Investment Management LP | 492,893 | $18M | — | 2026-06-30 | Filing |
| Siren, L.L.C. | 450,000 | $16M | — | 2026-06-30 | Filing |
| Capital World Investors | 415,730 | $15M | +415,730 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 402,051 | $14M | -79,150 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 364,705 | $13M | — | 2026-06-30 | Filing |
| DAFNA Capital Management LLC | 171,006 | $6M | — | 2026-06-30 | Filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A | 170,862 | $6M | -96,884 | 2026-06-30 | Filing |